Kazuo Nakamoto Selected Research

GW1100

8/2018	The involvement of free fatty acid-GPR40/FFAR1 signaling in chronic social defeat stress-induced pain prolongation in C57BL/6J male mice.
1/2017	Dysfunctional GPR40/FFAR1 signaling exacerbates pain behavior in mice.
12/2014	Involvement of GPR40, a long-chain free fatty acid receptor, in the production of central post-stroke pain after global cerebral ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuo Nakamoto Research Topics

Disease

22	Pain (Aches) 01/2022 - 01/2010
9	Hyperalgesia 01/2022 - 01/2013
7	Chronic Pain 01/2019 - 08/2010
5	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2010
5	Inflammation (Inflammations) 01/2022 - 01/2010
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 04/2009
3	Neuralgia (Stump Neuralgia) 05/2020 - 04/2015
3	Fibrosis (Cirrhosis) 01/2019 - 01/2012
3	Brain Ischemia (Cerebral Ischemia) 01/2019 - 10/2012
3	Fatty Liver 01/2016 - 11/2009
3	Neoplasms (Cancer) 01/2015 - 05/2013
3	Hypoxia (Hypoxemia) 11/2012 - 11/2009
2	Stroke (Strokes) 05/2020 - 12/2014
2	Glucose Intolerance 01/2020 - 10/2012
1	Postoperative Pain 01/2022
1	Ischemia 05/2020
1	Mental Disorders (Mental Disorder) 01/2019
1	Metabolic Diseases (Metabolic Disease) 02/2018
1	Necrosis 06/2017
1	Atrophy 02/2015
1	Cancer Pain 01/2014
1	Acute Pain 10/2013
1	Dehydration (Water Stress) 01/2013
1	Hyperglycemia 04/2011
1	Infections 04/2011
1	Rheumatoid Arthritis 01/2011
1	Edema (Dropsy) 01/2011
1	Dysmenorrhea (Menstrual Pain) 01/2011

Drug/Important Bio-Agent (IBA)

12	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 01/2012
8	Docosahexaenoic AcidsIBA 01/2022 - 01/2010
7	Nonesterified Fatty Acids (NEFA)IBA 01/2022 - 12/2014
7	Formaldehyde (Formol)FDA Link 01/2018 - 08/2010
6	GW9508IBA 01/2018 - 01/2012
5	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2019 - 09/2011
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2011
4	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022 - 01/2017
4	Pharmaceutical PreparationsIBA 05/2020 - 04/2011
4	EnzymesIBA 01/2019 - 04/2009
4	Choline (Choline Chloride)IBA 01/2019 - 01/2010
4	EndorphinsIBA 01/2018 - 01/2012
3	GW1100IBA 08/2018 - 12/2014
3	Freund's AdjuvantIBA 01/2018 - 01/2013
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2016 - 01/2010
3	Morphine (MS Contin)FDA LinkGeneric 10/2013 - 08/2010
2	Messenger RNA (mRNA)IBA 01/2022 - 06/2017
2	honokiolIBA 01/2020 - 10/2012
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019 - 02/2018
2	Methionine (L-Methionine)FDA Link 01/2019 - 02/2018
2	Alanine Transaminase (SGPT)IBA 01/2019 - 02/2018
2	CytokinesIBA 01/2019 - 02/2018
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2015 - 04/2011
2	Opioid Analgesics (Opioids)IBA 01/2014 - 05/2013
2	Analgesics (Analgesic Drugs)IBA 10/2013 - 12/2011
2	Sodium NitriteIBA 11/2012 - 11/2009
1	LipopolysaccharidesIBA 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	AH7614IBA 01/2022
1	Fatty Acid Binding Protein 3IBA 01/2022
1	Orexin ReceptorsIBA 05/2020
1	OrexinsIBA 05/2020
1	LipidsIBA 01/2019
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2019
1	AcidsIBA 01/2019
1	Amino Acids FDA Link 01/2019
1	N(G),N(G')-dimethylarginineIBA 01/2019
1	LigandsIBA 01/2019
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2019
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2019
1	Conditioned Culture MediaIBA 01/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2017
1	FatsIBA 01/2016
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 04/2015
1	Phenolsulfonphthalein (Phenol Red)IBA 02/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2015
1	Narcotics (Narcotic Analgesics)IBA 01/2015
1	Opiate AlkaloidsIBA 10/2013
1	alvocidib (flavopiridol)IBA 01/2013
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2013
1	NF-kappa B (NF-kB)IBA 11/2012
1	Surface Antigens (Surface Antigen)IBA 11/2012
1	PhycocyaninIBA 11/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2012
1	Neuroprotective AgentsIBA 10/2012
1	Peroxidase (Myeloperoxidase)IBA 01/2012
1	Therapeutic UsesIBA 01/2012
1	Opioid Receptors (Opioid Receptor)IBA 12/2011
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 12/2011
1	(trans)-Isomer 3,4- Dichloro- N- methyl- N- (2- (1- pyrrolidinyl)- cyclohexyl)- benzeneacetamideIBA 12/2011
1	Naloxone (Narcan)FDA LinkGeneric 09/2011
1	Glucose (Dextrose)FDA LinkGeneric 04/2011
1	damnacanthalIBA 01/2011

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2015 - 05/2013
2	Palliative Care (Palliative Therapy) 01/2015 - 05/2013
1	Parenteral Nutrition 02/2015
1	Oral Administration 01/2014
1	Therapeutics 01/2013
1	Fluid Therapy (Oral Rehydration Therapy) 01/2013
1	Spinal Injections 01/2013
1	Self Medication 01/2013
1	Warm Ischemia 01/2012